Dermobiane cheveux et ongles
Food supplement declared in France, declaration No 2017-10-575, decision dated 23 October 2017
Dermobiane cheveux et ongles, from PILEJE, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Bambusa bambos 143 mg per day, Pantothenic acid (vitamin B5), Biotin (vitamin B8), Copper, Folate (vitamin B9). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- PILEJE
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 2 gélules par jour
- Directions for use
- 2 gélules par jour, à avaler avec un verre d'eau.
- Not recommended (according to the manufacturer)
- Pregnant women
- Objectives stated by the manufacturer (these are not authorised claims)
- Hair and nails
Declaration 268848, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Bambusa bambos (L.) Voss | Exsudat | Extrait sec aqueux | 143 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Hydrolysat enzymatique de protéines de riz | not declared |
| Taurine | not declared |
| Chlorhydrate de L-cystéine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-pantothenate, calcium | Pantothenic acid (vitamin B5) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| D-biotin | Biotin (vitamin B8) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| cupric sulphate | Copper | 5,000 µg | 2,000 µg |
| pteroylmonoglutamic acid | Folate (vitamin B9) | 1,000 µg | 200 µg |
| nicotinamide | Nicotinamide (vitamin B3) | 900 mg | 54 mg |
| sodium selenite | Selenium | 255 µg | 50 µg |
| thiamin mononitrate | Vitamin B1 (thiamine) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| riboflavin | Vitamin B2 (riboflavin) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| pyridoxine hydrochloride | Vitamin B6 | 12 mg | 2 mg |
| D-alpha-tocopheryl acid succinate | Vitamin E | 300 mg | 30 mg |
| zinc sulphate | Zinc | 25 mg | 15 mg |
Additives
E553b, E470b
Other ingredients
Gélule végétale, maltodextrine
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Taurine
Read the warning, when it applies and the studies cited
TAURINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).
Sources cited by Health Canada (2)
- López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
- Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Dermobiane cheveux et ongles PILEJE, declared in 2017, earlier declaration, replaced by the 2017 declaration : different composition: 2 ingredient(s) added, 0 missing
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Dermobiane cheveux et ongles: composition and regulation”, https://compoatlas.com/en/supplements/products/268848-dermobiane-cheveux-et-ongles, updated 15 November 2026.